Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Palka

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Asian Journal of Andrology|December 22, 2007
Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndromeFlorina Raicu, Rossella Giuliani, Valentina Gatta, et al.
Journal of Human Genetics|November 9, 2006
Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assayValentina Gatta, Ivana Antonucci, Elisena Morizio, et al.
Gene|May 16, 2012
Array-CGH characterization of a de novo t(X;Y)(p22;q11) in a female with short stature and mental retardationChiara Palka-Bayard-de-Volo, Stefania De Marco, Valentina Chiavaroli, et al.
Prenatal Diagnosis|September 26, 2012
Optimal cut-offs for Down syndrome contingent screening in a population of 10,156 pregnant womenPaolo Guanciali-Franchi, Irene Iezzi, Alessandra Soranno, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|August 13, 2019
Non-invasive prenatal screening: A 20-year experience in ItalyChiara Palka, Paolo Guanciali-Franchi, Elisena Morizio, et al.
Plos One|December 8, 2017
Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosisPaolo Guanciali Franchi, Chiara Palka, Elisena Morizio, et al.
Prenatal Diagnosis|March 26, 2005
Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomalyClaudio Celentano, Paolo Emilio Guanciali-Franchi, Marco Liberati, et al.
Molecular Genetics & Genomic Medicine|November 30, 2016
Aneuploidy screening using circulating fetal cells in maternal blood by dual-probe FISH protocol: a prospective feasibility study on a series of 172 pregnant womenGiuseppe Calabrese, Donatella Fantasia, Melissa Alfonsi, et al.
BMC Medical Genetics|July 25, 2014
Spectrum of phenotypic anomalies in four families with deletion of the SHOX enhancer regionValentina Gatta, Chiara Palka, Valentina Chiavaroli, et al.
European Journal of Medical Genetics|March 1, 2011
Array-CGH characterization of a prenatally detected de novo 46,X,der(Y)t(X;Y)(p22.3;q11.2) in a male fetusChiara Palka, Melissa Alfonsi, Elisena Morizio, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Asian Journal of Andrology|December 22, 2007
Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndromeFlorina Raicu, Rossella Giuliani, Valentina Gatta, et al.
Journal of Human Genetics|November 9, 2006
Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assayValentina Gatta, Ivana Antonucci, Elisena Morizio, et al.
Gene|May 16, 2012
Array-CGH characterization of a de novo t(X;Y)(p22;q11) in a female with short stature and mental retardationChiara Palka-Bayard-de-Volo, Stefania De Marco, Valentina Chiavaroli, et al.
Prenatal Diagnosis|September 26, 2012
Optimal cut-offs for Down syndrome contingent screening in a population of 10,156 pregnant womenPaolo Guanciali-Franchi, Irene Iezzi, Alessandra Soranno, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|August 13, 2019
Non-invasive prenatal screening: A 20-year experience in ItalyChiara Palka, Paolo Guanciali-Franchi, Elisena Morizio, et al.
Plos One|December 8, 2017
Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosisPaolo Guanciali Franchi, Chiara Palka, Elisena Morizio, et al.
Prenatal Diagnosis|March 26, 2005
Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomalyClaudio Celentano, Paolo Emilio Guanciali-Franchi, Marco Liberati, et al.
Molecular Genetics & Genomic Medicine|November 30, 2016
Aneuploidy screening using circulating fetal cells in maternal blood by dual-probe FISH protocol: a prospective feasibility study on a series of 172 pregnant womenGiuseppe Calabrese, Donatella Fantasia, Melissa Alfonsi, et al.
BMC Medical Genetics|July 25, 2014
Spectrum of phenotypic anomalies in four families with deletion of the SHOX enhancer regionValentina Gatta, Chiara Palka, Valentina Chiavaroli, et al.
European Journal of Medical Genetics|March 1, 2011
Array-CGH characterization of a prenatally detected de novo 46,X,der(Y)t(X;Y)(p22.3;q11.2) in a male fetusChiara Palka, Melissa Alfonsi, Elisena Morizio, et al.
Pageof 3